Immunization with a replication-deficient mutant of herpes simplex virus type 1 (HSV-1) induces a CD8+ cytotoxic T-lymphocyte response and confers a level of protection comparable to that of wild-type HSV-1

Journal of Virology

Volumn 71, Issue 5, 1997, Pages 3534-3544

  Brehm, Michael A ^a   Bonneau, Robert H ^a   Knipe, David M ^b   Tevethia, Satvir S ^a,c  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN;

ADOPTIVE TRANSFER; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; HERPES SIMPLEX VIRUS 1; IMMUNIZATION; IMMUNOSTIMULATION; LYMPHOCYTE ACTIVATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; VIRUS MUTANT; VIRUS REPLICATION;

EID: 0030944587     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.71.5.3534-3544.1997     Document Type: Article

References (81)

1. Babu, J. S., J. Thomas, S. Kanangat, L. A. Morrison, D. M. Knipe, and B. T. Rouse. 1996. Viral replication is required for induction of ocular immunopathology by herpes simplex virus. J. Virol. 70:101-107.
2. Banks, T. A., S. Nair, and B. T. Rouse. 1993. Recognition by and in vitro induction of cytotoxic T lymphocytes against predicted epitopes of the immediate-early protein ICP27 of herpes simplex virus. J. Virol. 67:613-616.
3. Blacklaws, B., and A. A. Nash. 1990. Immunological memory to herpes simplex virus type 1 glycoproteins B and D in mice. J. Gen. Virol. 71:863-871.
4. Blacklaws, B. A., S. Krishna, A. C. Minson, and A. A. Nash. 1990. Immunogenicity of herpes simplex virus type 1 glycoproteins expressed in vaccinia virus recombinants. Virology 177:727-736.
5. Blacklaws, B. A., A. A. Nash, and G. Darby. 1987. Specificity of the immune response of mice to herpes simplex virus glycoproteins B and D constitutively expressed on L cell lines. J. Gen. Virol. 68:1103-1114.
6. Bonneau, R. H., J. F. Sheridan, N. G. Feng, and R. Glaser. 1991. Stress-induced effects on cell-mediated innate and adaptive memory components of the murine immune response to herpes simplex virus infection. Brain Behav. Immun. 5:274-295.
7. Bonneau, R. H., T.-M. Fu, and S. S. Tevethia. 1993. In vivo priming and activation of memory cytotoxic T-lymphocytes (CTL) by a chimeric simian virus 40 T antigen expressing an eight amino acid residue herpes simplex virus gB CTL epitope. Virology 197:782-787.
8. Bonneau, R. H., and S. R. Jennings. 1989. Modulation of acute and latent herpes simplex virus infection C57BL/6 mice by adoptive transfer of immune lymphocytes with cytolytic activity. J. Virol. 63:1480-1484.
9. Bonneau, R. H., and S. R. Jennings. 1990. Herpes simplex virus-specific cytolytic T lymphocytes restricted to a normally low responder H-2 allele are protective in vivo. Virology 174:599-604.
10. b-restricted, HSV-1- and HSV-2-cross-reactive cytotoxic T lymphocyte clones. Virology 195:62-70.
11. Bouley, D. M., S. Kanangat, W. Wire, and B. T. Rouse. 1995. Characterization of herpes simplex virus type-1 infection and herpetic stromal keratitis development in IFN-γ knockout mice. J. Immunol. 155:3964-3971.
12. Burke, R. L. 1993. Current developments in herpes simplex virus vaccines. Semin. Virol. 4:187-189.
13. Burke, R. L., C. Goldbeck, P. Ng, L. Stanberry, G. Ott, and G. V. Nest. 1994. The influence of adjuvant on the therapeutic efficacy of a recombinant genital herpes vaccine. J. Infect. Dis. 170:1110-1119.
14. Cantin, E. M., R. Eberle, J. L. Baldick, B. Moss, D. E. Willey, A. L. Notkins, and H. Openshaw. 1987. Expression of herpes simplex virus type 1 glycoprotein B by a recombinant vaccinia virus and protection of mice against a lethal herpes simplex 1 infection. Proc. Natl. Acad. Sci. USA 84:5908-5912.
15. Carter, V. C., P. A. Schaffer, and S. S. Tevethia. 1981. The involvement of herpes simplex virus type-1 glycoproteins in cell mediated immunity. J. Immunol. 126:1655-1660.
16. Dix, R. D., L. Pereira, and J. R. Baringer. 1981. Use of monoclonal antibodies directed against herpes simplex virus glycoproteins to protect mice against acute virus-induced neurological disease. Infect. Immun. 34:195-199.
17. Doherty, P. C. 1995. Immune memory to viruses. ASM News 61:68-71.
18. Farrell, H. E., C. S. McLean, C. Harley, S. Efstathiou, S. Inglis, and A. C. Minson. 1994. Vaccine potential of a herpes simplex virus type 1 mutant with an essential glycoprotein deleted. J. Virol. 68:927-932.
19. Forrester, A J., and A. A. Nash. 1991. Induction of protective immunity with antibody to herpes simplex virus type 1 glycoprotein H (gH) and analysis of the immune response to gH expressed in recombinant vaccinia virus. J. Gen. Virol. 72:369-375.
20. Fu, T.-M., R. H. Bonneau, M. Epler, M. J. Tevethia, S. Alam, K. Verner, and S. S. Tevethia. 1996. Induction and persistence of a cytotoxic T lymphocyte (CTL) response against a herpes simplex virus-specific CTL epitope expressed in a cellular protein. Virology 222:269-274.
21. Gallichan, W. S., D. C. Johnson, F. L. Graham, and K. L. Rosenthal. 1993. Mucosal immunity and protection after intranasal immunization with recombinant adenovirus expressing herpes simplex virus glycoprotein B. J. Infect. Dis. 168:622-629.
22. Gao, M., and D. M. Knipe. 1989. Genetic evidence for multiple nuclear functions of the herpes simplex virus ICP8 DNA-binding protein. J. Virol. 63:5258-6267.
23. Ghiasi, H., S. Cai, S. Slanina, A. B. Nesburn, and S. L. Wechsler. 1995. Vaccination of mice with herpes simplex virus type 1 glycoprotein D DNA produces low levels of protection against lethal HSV-1 challenge. Antiviral Res. 28:147-157.
24. Ghiasi, H., R. Kaiwar, A. B. Nesburn, S. Slanina, and S. L. Wechsler. 1992. Baculovirus-expressed glycoprotein E (gE) of herpes simplex virus type-1 (HSV-1) protects mice against lethal intraperitoneal and lethal ocular HSV-1 challenge. Virology 188:469-476.
25. Ghiasi, H., R. Kaiwar, A. B. Nesburn, S. Slanina, and S. L. Wechsler. 1994. Expression of seven herpes simplex virus type 1 glycoproteins (gB, gC, gD, gE, gG, gH, and gI): comparative protection against lethal challenge in mice. J. Virology 68:2118-2126.
26. Ghiasi, H., R. Kaiwar, A. B. Nesburn, and S. L. Wechsler. 1992. Baculovirus-expressed glycoprotein G of herpes simplex virus type 1 partially protects vaccinated mice against lethal HSV-1 challenge. Virology 190:233-239.
27. Glorioso, J., U. Kees, G. Kumel, H. Kirchner, and P. H. Krammer. 1985. Identification of herpes simplex virus type 1 (HSV-1) glycoprotein gC as the immunodominant antigen for HSV-1-specific memory cytotoxic T lymphocytes. J. Immunol. 135:575-582.
28. Hanke, T., F. L. Graham, K. L. Rosenthal, and D. C. Johnson. 1991. Identification of an immunodominant cytotoxic T-lymphocyte recognition site in glycoprotein B of herpes simplex virus by using recombinant adenovirus vectors and synthetic peptides. J. Virol. 65:1177-1186.
29. Hengel, H., M. Lindner, H. Wagner, and K. Heeg. 1987. Frequency of herpes simplex virus-specific murine cytotoxic T lymphocyte precursors in mitogen- and antigen-driven primary in vitro T cell responses. J. Immunol. 139:4196-4202.
30. + T-cell memory determined by clonal burst size. Nature 369:652-654.
31. Igietseme, J. U., P. J. Calzada, A. R. Gonzalez, J. W. Streilein, and S. S. Atherton. 1989. Protection of mice from herpes simplex virus retinitis by in vitro-activated immune cells. J. Virol. 63:4808-4813.
32. Jennings, S. R., R. H. Bonneau, P. M. Smith, R. M. Wolcott, and R. Chervenak. 1991. CD4-positive T lymphocytes are required for the generation of the primary but not the secondary CD8-positive cytolytic T lymphocyte response to herpes simplex virus in C57BL/6 mice. Cell. Immunol. 133:234-252.
33. Jennings, S. R., K. L. Fresa, P. A. Lippe, J. E. Milici, and S. S Tevethia. 1988. Frequencv analysis of simian virus 40-specific cytotoxic T lymphocyte precursors in the high responder C57BL/6 mouse strain. J. Gen. Virol. 69:2493-2503.
34. Jennings, S. R., P. L. Rice, E. D. Kloszewski, R. W. Anderson, D. L. Thompson, and S. S. Tevethia. 1985. Effect of herpes simplex virus types 1 and 2 on surface expression of class I major histocompatibility complex antigens on infected cells. J. Virol. 56:757-766.
35. b haplotype by virus-specific cytotoxic T lymphocytes. J. Immunol. 132:475-481.
36. Johnson, D. C., and P. G. Spear. 1982. Monensin inhibits the processing of herpes simplex virus glycoproteins, their transport to the cell surface, and egress of virions from infected cells. J. Virol. 43:1102-1112.
37. Kapoor, A. K., A. A. Nash, P. Wildy, J. Phelan, C. S. McLean, and H. J. Field. 1982. Pathogenesis of herpes simplex virus in congenitally athymic mice: the relative roles of cell-mediated and humoral immunity. J. Gen. Virol. 60:225-233.
38. Kierstead, T. D., and M. J. Tevethia. 1993. Association of p53 binding and immortalization of primary C57BL/6 mouse embryo fibroblasts by using simian virus 40 T-antigen mutants bearing internal overlapping deletion mutations. J. Virol. 67:1817-1829.
39. Krishna, S., B. A. Blacklaws, H. A. Overton, D. H. L. Bishop, and A. A. Nash. 1989. Expression of glycoprotein D of Herpes simplex virus type 1 in a recombinant baculovirus: protective responses and T cell recognition of recombinant-infected cell extracts. J. Gen. Virol. 70:1805-1814.
40. Langenberg, A. G. M., R. L. Burke, S. F. Adair, R. Sekulovich, M. Tigges, C. L. Dekker, and L. Corey. 1995. A recombinant glycoprotein vaccine for herpes simplex type 2: safety and efficacy. Ann. Intern. Med. 122:889-898.
41. Larsen, H. S., M. Feng, D. W. Horohov, R. N. Moore, and B. T. Rouse. 1984. Role of T-lymphocyte subsets in recovery from herpes simplex virus infection. J. Virol. 50:56-59.
42. Larsen, H. S., R. G. Russell, and B. T. Rouse. 1983. Recovery from lethal herpes simplex virus type 1 infection is mediated by cytotoxic T lymphocytes. Infect. Immun. 41:197-204.
43. Lawman, M. B., B. T. Rouse, R. J. Courtney, and R. D. Walker. 1980. Cell-mediated immunity against herpes simplex induction of cytotoxic T lymphocytes. Infect. Immun. 27:133-139.
44. + cells. J. Virol. 69:4711-4716.
45. Manickan, E., and B. T. Rouse. 1995. Roles of different T-cell subsets in control of herpes simplex virus infection determined by using T-cell-deficient mouse models. J. Virol. 69:8178-8179.
46. Manickan, E., R. J. D. Rouse, Z. Yu, S. Wire, and B. T. Rouse. 1995. Genetic immunization against herpes simplex virus. J. Immunol. 155:259-265.
47. Martin, S., B. Moss, P. W. Berman, L. A. Laskey, and B. T. Rouse. 1987. Mechanisms of antiviral immunity induced by a vaccinia virus recombinant expressing herpes simplex type 1 glycoprotein D: cytotoxic T cells. J. Virol. 61:726-734.
48. Martin, S., and B. T. Rouse. 1987. The mechanisms of antiviral immunity induced by a vaccinia virus recombinant expressing herpes simplex virus type 1 glycoprotein D: clearance of local infection. J. Immunol. 138:3431-3437.
49. McDermott, M., F. L. Graham, T. Hanke, and D. C. Johnson. 1989. Protection of mice against lethal challenge with herpes simplex virus by vaccination with an adenovirus vector expressing HSV glycoprotein B. Virology 169:244-247.
50. McLaughlin-Taylor, E., D. E. Willey, E. M. Cantin, R. Eberle, B. Moss, and H. Openshaw. 1988. A recombinant vaccinia virus expressing herpes simplex virus type 1 glycoprotein B induces cytotoxic T lymphocytes in mice. J. Gen. Virol. 69:1731-1734.
51. McLean, C. S., M. Erturk, R. Jennings, D. N. Challanain, A. C. Minson, I. Duncan, M. E. G. Boursnell, and S. C. Inglis. 1994. Protective vaccination against primary and recurrent disease caused by herpes simplex virus (HbV) type 2 using a genetically disabled HSV-1. J. Infect. Dis. 170:1100-1109.
52. Meignier, B. 1991. Genetically engineered attenuated herpes simplex viruses. Rev. Infect. Dis. 13:s895-s897.
53. Mitchell, B. M., and J. G. Stevens. 1996. Neuroinvasive properties of herpes simplex virus type 1 glycoprotein varients are controlled by the immune response. J. Immunol. 156:246-255.
54. Morrison, L. A., and D. M. Knipe. 1994. Immunization with replication-defective mutants of herpes simplex virus type 1: sites of immune intervention in pathogenesis of challenge virus infection. J. Virol. 68:689-696.
55. Morrison, L. A., and D. M. Knipe. 1996. Mechanisms of immunization with a replication-defective mutant of herpes simplex virus 1. Virology 220:402-413.
56. Nash, A. A., and P. Cambouropoulos. 1993. The immune response to herpes simplex virus. Semin. Virol. 4:181-186.
57. Nash, A. A., H. J. Field, and R. Quartey-Papafio. 1980. Cell-mediated immunity in herpes simplex virus-infected mice: induction, characterization and antiviral effects of delayed type hypersensitivity. J. Gen. Virol. 48:351-357.
58. Nash, A. A., J. Phelan, and P. Wildy. 1981. Cell-mediated immunity in herpes simplex virus-infected mice: H-2 mapping of the delayed-type hypersensitivity response and the antiviral T cell response. J. Immunol. 126:1260-1262.
59. Nash, A. A., R. Quartey-Papafio, and P. Wildy. 1980. Cell-mediated immunity in herpes simplex virus infected mice: functional analysis of lymph node cells during periods of acute and latent infection, with reference to cytotoxic and memory cells. J. Gen. Virol. 49:309-317.
60. Nguyen, L. H., D. M. Knipe, and R. W. Finberg. 1992. Replication-defective mutants of herpes simplex virus (HSV) induce cellular immunity and protect against lethal HSV infection. J. Virol. 66:7067-7072.
61. Nugent, C. T., R. M. Wolcott, R. Chervenak, and S. R. Jennings. 1994. Analysis of the cytolytic T-lymphocyte response to herpes simplex virus type 1 glycoprotein B during primary and secondary infection. J. Virol. 68:7644-7648.
62. Pfizenmaier, K., H. Jung, A. Starzinski-Powitz, M. Rollinghoff, and H. Wagner. 1977. The role of T cells in anti-herpes immunity. I. Induction of antigen-specific cytotoxic T lymphocytes. J. Immunol. 119:939-944.
63. Pfizenmaier, K., A. Starzinski-Powitz, M. Rollinghoff, and H. Wagner. 1977. T-cell-mediated cytotoxicity against herpes simplex virus-infected target cells. Nature 265:630-632.
64. + cytotoxic T-lymphocyte precursors specific for herpes simplex viruses in persons with genital herpes. J. Virol. 70:8165-8168.
65. Pretell, J., R. S. Greenfield, and S. S. Tevethia. 1979. Biology of simian virus 40 (SV40) transplantation rejection antigen (TrAg). V. In vitro demonstration of SV40 TrAg in SV40-infected permissive mouse cells by the lymphocyte mediated cytotoxicity assay. Virology 97:32-41.
66. Rinaldo, C. R., and D. J. Torpey. 1993. Cell-mediated immunity and immunosuppression in herpes simplex virus infection. Immunodeficiency 5:33-90.
67. Rosenthal, K. L., J. R. Smiley, S. South, and D. C. Johnson. 1987. Cells expressing herpes simplex virus glycoprotein gC but not gB, gD, or gE are recognized by murine virus-specific cytotoxic T lymphocytes. J. Virol. 61: 2438-2447.
68. Rouse, B. T., H. S. Larsen, and H. Wagner. 1983. Frequency of cytotoxic T lymphocyte precursors to herpes simplex virus type 1 as determined by limiting dilution analysis. Infect. Immun. 39:785-792.
69. Schmid, D. S., and B. T. Rouse. 1992. The role of T cell immunity in control of herpes simplex virus. Curr. Top. Microbiol. Immunol. 179:57-74.
70. Sethi, K. K., Y. Omata, and K. E. Schneweis. 1983. Protection of mice from fatal herpes simplex virus type 1 infection by adoptive transfer of cloned virus-specific and H-2-restricted cytotoxic T lymphocytes. J. Gen. Virol. 64:443-447.
71. Simmons, A., and A. A. Nash. 1985. Role of antibody in primary and recurrent herpes simplex virus infection. J. Virol. 53:944-948.
72. Simmons, A., and D. C. Tscharke. 1992. Anti-CD8 impairs clearance of herpes simplex virus from the nervous system: implications for the fate of virally infected neurons. J. Exp. Med. 175:1337-1344.
73. Smith, P. M., R. M. Wolcott, R. Chervenak, and S. R. Jennings. 1994. Control of acute cutaneous herpes simplex virus infection: T cell-mediated viral clearance is dependent upon interferon-γ (IFN-γ). Virology 202:76-38.
74. Straus, S. E., L. Corey, R. L. Burke, B. Savarese, G. Barnum, P. R. Frause, R. G. Kost, J. L. Meier, R. Sekulovich, S. F. Adair, and C. L. Dekker. 1994. Placebo-controlled trial of vaccination with recombinant glycoprotein D of herpes simplex virus type 2 for immunotherapy of genital herpes. Lancet 343:1460-1463.
75. Tanaka, Y., and S. S. Tevethia. 1988. In vitro selection of SV40 T antigen epitope loss variants by site specific cytotoxic T lymphocyte clone. J. Immunol. 140:4348-4354.
76. Tanaka, Y., and S. S. Tevethia. 1990. Loss of immunorecessive cytotoxic T lymphocyte determinant V on SV40 T antigen following cocultivation with site-specific cytotoxic T lymphocyte clone Y-5. Intervirology 31:197-202.
77. Taswell, C. 1981. Limiting dilution assays for the determination of immunocompetent cell frequencies. I. Data analysis. J. Immunol. 126:1614-1620.
78. Walker, C., M. Selby, A. Erickson, D. Cataldo, J. P. Valensi, and G. V. Nest. 1992. Cationic lipids direct a viral glycoprotein into the class I major histocompatibility complex antigen-presentation pathway. Proc. Natl. Acad. Sci. USA 89:7915-7918.
79. Ward, P. L., and B. Roizman. 1994. Herpes simplex genes: the blueprint of a successful pathogen. Trends Genet. 10:267-274.
80. Whitley, R. J. 1993. Prospects for vaccination against herpes simplex virus. Pediatr. Ann. 22:728-731.
81. Wu, L., and P. S. Morahan. 1992. Other nonspecific defenses: role in modulating resistance against herpes simplex virus. Curr. Top. Microbiol. Immunol. 179:89-110.